238 related articles for article (PubMed ID: 8265609)
21. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a neutralizing monoclonal antibody to the external glycoprotein of HIV-1.
Pal R; di Marzo Veronese F; Nair BC; Rahman R; Hoke G; Mumbauer SW; Sarngadharan MG
Intervirology; 1992; 34(2):86-93. PubMed ID: 1284059
[TBL] [Abstract][Full Text] [Related]
23. Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis.
Mizukami T; Fuerst TR; Berger EA; Moss B
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9273-7. PubMed ID: 2461565
[TBL] [Abstract][Full Text] [Related]
24. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
[TBL] [Abstract][Full Text] [Related]
25. Increased production of human immunodeficiency virus (HIV) in HIV-induced syncytia formation: an efficient infection process.
Chowdhury MI; Koyanagi Y; Suzuki M; Kobayashi S; Yamaguchi K; Yamamoto N
Virus Genes; 1992 Jan; 6(1):63-78. PubMed ID: 1347963
[TBL] [Abstract][Full Text] [Related]
26. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
[TBL] [Abstract][Full Text] [Related]
27. Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding.
Celada F; Cambiaggi C; Maccari J; Burastero S; Gregory T; Patzer E; Porter J; McDanal C; Matthews T
J Exp Med; 1990 Oct; 172(4):1143-50. PubMed ID: 2212945
[TBL] [Abstract][Full Text] [Related]
28. Separation and partial characterization of proteinases with substrate specificity for basic amino acids from human MOLT-4 T lymphocytes: identification of those inhibited by variable-loop-V3 peptides of HIV-1 (human immunodeficiency virus-1) envelope glycoprotein.
Harvima IT; Harvima RJ; Nilsson G; Ivanoff L; Schwartz LB
Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):711-8. PubMed ID: 8318003
[TBL] [Abstract][Full Text] [Related]
29. Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.
Jiang X; Totrov M; Li W; Sampson JM; Williams C; Lu H; Wu X; Lu S; Wang S; Zolla-Pazner S; Kong XP
J Virol; 2016 Dec; 90(24):11007-11019. PubMed ID: 27707920
[TBL] [Abstract][Full Text] [Related]
30. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
[TBL] [Abstract][Full Text] [Related]
31. Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncytium induction by human immunodeficiency virus.
Wilks D; Walker L; O'Brien J; Habeshaw J; Dalgleish A
Immunology; 1990 Sep; 71(1):10-5. PubMed ID: 2210798
[TBL] [Abstract][Full Text] [Related]
32. Synergistic inhibition of HIV-1 envelope-mediated cell fusion by CD4-based molecules in combination with antibodies to gp120 or gp41.
Allaway GP; Ryder AM; Beaudry GA; Maddon PJ
AIDS Res Hum Retroviruses; 1993 Jul; 9(7):581-7. PubMed ID: 8369162
[TBL] [Abstract][Full Text] [Related]
33. Characterization of T cell-expressed chimeric receptors with antibody-type specificity for the CD4 binding site of HIV-1 gp120.
Bitton N; Verrier F; Debré P; Gorochov G
Eur J Immunol; 1998 Dec; 28(12):4177-87. PubMed ID: 9862354
[TBL] [Abstract][Full Text] [Related]
34. Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody.
Chen SY; Khouri Y; Bagley J; Marasco WA
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5932-6. PubMed ID: 8016092
[TBL] [Abstract][Full Text] [Related]
35. Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection.
Zanotto C; Calderazzo F; Dettin M; Di Bello C; Autiero M; Guardiola J; Chieco-Bianchi L; De Rossi A
Virology; 1995 Feb; 206(2):807-16. PubMed ID: 7856094
[TBL] [Abstract][Full Text] [Related]
36. Synthetic peptides derived from the variable regions of an anti-CD4 monoclonal antibody bind to CD4 and inhibit HIV-1 promoter activation in virus-infected cells.
Monnet C; Laune D; Laroche-Traineau J; Biard-Piechaczyk M; Briant L; Bès C; Pugnière M; Mani JC; Pau B; Cerutti M; Devauchelle G; Devaux C; Granier C; Chardès T
J Biol Chem; 1999 Feb; 274(6):3789-96. PubMed ID: 9920932
[TBL] [Abstract][Full Text] [Related]
37. Class II MHC molecules and the HIV gp 120 envelope protein interact with functionally distinct regions of the CD4 molecule.
Lamarre D; Capon DJ; Karp DR; Gregory T; Long EO; Sékaly RP
EMBO J; 1989 Nov; 8(11):3271-7. PubMed ID: 2555159
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Celada F; Düzgüneş N
J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
[TBL] [Abstract][Full Text] [Related]
39. Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1).
Pal R; Nair BC; Hoke GM; Sarngadharan MG; Edidin M
J Cell Physiol; 1991 May; 147(2):326-32. PubMed ID: 2040664
[TBL] [Abstract][Full Text] [Related]
40. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
Qiao Y; Man L; Qiu Z; Yang L; Sun Y; He Y
Antiviral Res; 2016 Aug; 132():252-61. PubMed ID: 27387828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
